Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report
Sign Up to like & getrecommendations! Published in 2018 at "Infection"
DOI: 10.1007/s15010-018-1242-1
Abstract: BackgroundHepatitis B virus (HBV) reactivation is commonly observed in HBsAg-positive hematologic patients undergoing immunosuppressive chemotherapy. Recent guidelines recommend antiviral prophylaxis to be continued for up to 12 months after the discontinuation of the anticancer regimen.Case… read more here.
Keywords: hbv; hbv reactivation; rituximab containing; reactivation ... See more keywords
Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection.
Sign Up to like & getrecommendations! Published in 2021 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2021.107606
Abstract: Patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) have a poor prognosis. This study investigated the efficacy of rituximab-containing immuno-chemotherapy regimens for EBV-HLH. In this study, 15 patients were treated with rituximab-containing regimens. The treatment efficacy… read more here.
Keywords: ebv hlh; containing immuno; immuno chemotherapy; rituximab containing ... See more keywords
Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-69465-2
Abstract: Cold agglutinin disease (CAD) is a rare form of autoimmune haemolytic anaemia, and because of its rareness, there is no standard treatment for CAD patients. We retrospectively analysed the response to rituximab-containing therapy in CAD… read more here.
Keywords: containing therapy; disease; cold agglutinin; rituximab containing ... See more keywords
Increased C-Reactive Protein Level Is Associated with Poor Prognosis in Patients with Follicular Lymphoma Treated with Rituximab-Containing Regimens
Sign Up to like & getrecommendations! Published in 2017 at "Blood"
DOI: 10.1182/blood.v130.suppl_1.4067.4067
Abstract: Introduction: C-reactive protein (CRP) is a useful inflammatory marker in clinical practice. It is a prognostic factor in several types of tumors, including diffuse large B cell lymphoma (DLBCL) and extranodal natural killer/T-cell lymphoma, nasal… read more here.
Keywords: elevated crp; containing regimens; associated poor; rituximab containing ... See more keywords
Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
Sign Up to like & getrecommendations! Published in 2021 at "Cancers"
DOI: 10.3390/cancers13081760
Abstract: Simple Summary The current literature on NLPHL therapy is scarce due to the disease rarity. Our study aims to focus on the management and treatment strategies of NLPHL based on risk stratification. This paper contributes… read more here.
Keywords: risk; treatment; historical cohort; rituximab containing ... See more keywords